Search - tctmd.com

Displaying 801 - 820 of 1511

Sort: Relevancy | Date

News Industry News

India Coronary Stent Market to be Tripled by 2021

May 05, 2015

News Industry News

New Data Evaluating The Boston Scientific Eluvia™ Drug-Eluting Vascular Stent System Demonstrate 94.4 Percent Primary Patency Rate At Nine Months

April 28, 2015

News Daily News

Meta-analyses Shed Light on the Impact of DAPT Duration

Caitlin E. Cox

April 03, 2015

News Daily News

DAPT Substudy: No Apparent Benefit of Long-term DAPT in BMS Patients

Yael L. Maxwell

March 24, 2015

News Industry News

Medtronic Initiates Pivotal Studies of Resolute Onyx(TM) Drug-Eluting Stent in United States

March 12, 2015

News Daily News

ITALIC Published: No Benefit to Long-Term DAPT After Stenting

Yael L. Maxwell

March 10, 2015

News Daily News

DCB Matches DES in Treating ‘Real-World’ Patients With In-Stent Restenosis

March 04, 2015

News Daily News

ZEUS Published: ZES With Personalized DAPT Bests Bare-Metal Stent in ‘Uncertain’ DES Candidates

L.A. McKeown

February 25, 2015

Presentation CADECI 2015

The future of Drug-Eluting Stent

Presenter: Renu Virmani

February 18, 2015

News Daily News

Eyeballing of Lesion Lengths Often Inaccurate, Can Impair Stent Choice

Yael L. Maxwell

January 29, 2015

News Daily News

PCI No Less Effective in High-BMI Patients Despite Greater Plaque Burden

January 28, 2015

News Daily News

Los SLF con Polímero Biodegradable son Seguros y Duraderos al cabo de 5 Años

L.A. McKeown

January 28, 2015

News Daily News

DES With Biodegradable Polymer Safe, Durable Through 5 Years

L.A. McKeown

January 28, 2015

News Daily News

CABG, DES Yield Similar Outcomes in Isolated Proximal LAD Disease

Todd Neale

December 22, 2014

News Daily News

Drug-Coated Balloon Beats Angioplasty Alone in PAD Patients

Salynn Boyles

December 15, 2014

News Industry News

InspireMD Announces Important Clinical Data from MASTER and CARENET Trials

December 14, 2014

News Industry News

New Data From EVOLVE Clinical Program Demonstrate SYNERGY™ Bioabsorbable Polymer Stent Meets Key Performance Endpoints

November 18, 2014

News Conference News AHA 2014

Biodegradable-Polymer DES Perform Well But Appear No Safer than Their Durable-Polymer Counterparts

November 18, 2014

News Daily News

SORT OUT III Substudy Hints at Differences in DES Efficacy Based on Diabetes Status

Todd Neale

November 17, 2014

News Daily News

SECURITY: 6 Months of DAPT Noninferior to 12 Months in Low-Risk Patients After PCI

Yael L. Maxwell

November 17, 2014

Advertisement

India Coronary Stent Market to be Tripled by 2021

New Data Evaluating The Boston Scientific Eluvia™ Drug-Eluting Vascular Stent System Demonstrate 94.4 Percent Primary Patency Rate At Nine Months

Meta-analyses Shed Light on the Impact of DAPT Duration

DAPT Substudy: No Apparent Benefit of Long-term DAPT in BMS Patients

Medtronic Initiates Pivotal Studies of Resolute Onyx(TM) Drug-Eluting Stent in United States

ITALIC Published: No Benefit to Long-Term DAPT After Stenting

DCB Matches DES in Treating ‘Real-World’ Patients With In-Stent Restenosis

ZEUS Published: ZES With Personalized DAPT Bests Bare-Metal Stent in ‘Uncertain’ DES Candidates

The future of Drug-Eluting Stent

Eyeballing of Lesion Lengths Often Inaccurate, Can Impair Stent Choice

PCI No Less Effective in High-BMI Patients Despite Greater Plaque Burden

Los SLF con Polímero Biodegradable son Seguros y Duraderos al cabo de 5 Años

DES With Biodegradable Polymer Safe, Durable Through 5 Years

CABG, DES Yield Similar Outcomes in Isolated Proximal LAD Disease

Drug-Coated Balloon Beats Angioplasty Alone in PAD Patients

InspireMD Announces Important Clinical Data from MASTER and CARENET Trials

New Data From EVOLVE Clinical Program Demonstrate SYNERGY™ Bioabsorbable Polymer Stent Meets Key Performance Endpoints

Biodegradable-Polymer DES Perform Well But Appear No Safer than Their Durable-Polymer Counterparts

SORT OUT III Substudy Hints at Differences in DES Efficacy Based on Diabetes Status

SECURITY: 6 Months of DAPT Noninferior to 12 Months in Low-Risk Patients After PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content